From Wikipedia, the free encyclopedia
Pharmaceutical drug classification
ATC code C10 Lipid modifying agents is a therapeutic subgroup of the
Anatomical Therapeutic Chemical Classification System , a system of alphanumeric codes developed by the
World Health Organization (WHO) for the classification of
drugs and other medical products.
[1]
[2]
[3] Subgroup C10 is part of the anatomical group
C Cardiovascular system .
[4]
Codes for
veterinary use (
ATCvet codes ) can be created by placing the letter Q in front of the human ATC code: for example, QC10 .
[5] National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
C10A Lipid modifying agents, plain
C10AA HMG CoA reductase inhibitors
C10AA01
Simvastatin
C10AA02
Lovastatin
C10AA03
Pravastatin
C10AA04
Fluvastatin
C10AA05
Atorvastatin
C10AA06
Cerivastatin
C10AA07
Rosuvastatin
C10AA08
Pitavastatin
C10AB Fibrates
C10AB01
Clofibrate
C10AB02
Bezafibrate
C10AB03
Aluminium clofibrate
C10AB04
Gemfibrozil
C10AB05
Fenofibrate
C10AB06
Simfibrate
C10AB07
Ronifibrate
C10AB08
Ciprofibrate
C10AB09
Etofibrate
C10AB10
Clofibride
C10AB11
Choline fenofibrate
C10AB12
Pemafibrate
C10AC Bile acid sequestrants
C10AC01
Colestyramine
C10AC02
Colestipol
C10AC03
Colextran
C10AC04
Colesevelam
C10AD Nicotinic acid and derivatives
C10AD01
Niceritrol
C10AD02
Nicotinic acid
C10AD03
Nicofuranose
C10AD04
Aluminium nicotinate
C10AD05
Nicotinyl alcohol (pyridylcarbinol)
C10AD06
Acipimox
C10AD52 Nicotinic acid, combinations
C10AX Other lipid modifying agents
C10AX01
Dextrothyroxine
C10AX02
Probucol
C10AX03
Tiadenol
C10AX05
Meglutol
C10AX06
Omega-3-triglycerides
C10AX07
Magnesium pyridoxal 5-phosphate glutamate
C10AX08
Policosanol
C10AX09
Ezetimibe
C10AX10
Alipogene tiparvovec
C10AX11
Mipomersen
C10AX12
Lomitapide
C10AX13
Evolocumab
C10AX14
Alirocumab
C10AX15
Bempedoic acid
C10AX16
Inclisiran
C10AX17
Evinacumab
C10AX18
Volanesorsen
C10B Lipid modifying agents, combinations
C10BA Combinations of various lipid modifying agents
C10BA01
Lovastatin and nicotinic acid
C10BA02
Simvastatin and ezetimibe
C10BA03
Pravastatin and fenofibrate
C10BA04
Simvastatin and fenofibrate
C10BA05
Atorvastatin and ezetimibe
C10BA06 Rosuvastatin and ezetimibe
C10BA07 Rosuvastatin and
omega-3 fatty acids
C10BA08 Atorvastatin and omega-3 fatty acids
C10BA09 Rosuvastatin and fenofibrate
C10BA10
Bempedoic acid and ezetimibe
C10BA11 Pravastatin and ezetimibe
C10BA12 Pravastatin, ezetimibe and fenofibrate
C10BX Lipid modifying agents in combination with other drugs
C10BX01 Simvastatin and
acetylsalicylic acid
C10BX02 Pravastatin and acetylsalicylic acid
C10BX03
Atorvastatin and amlodipine
C10BX04 Simvastatin, acetylsalicylic acid and
ramipril
C10BX05 Rosuvastatin and acetylsalisylic acid
C10BX06 Atorvastatin, acetylsalicylic acid and ramipril
C10BX07 Rosuvastatin,
amlodipine and
lisinopril
C10BX08 Atorvastatin and acetylsalicylic acid
C10BX09 Rosuvastatin and amlodipine
C10BX10 Rosuvastatin and
valsartan
C10BX11 Atorvastatin, amlodipine and
perindopril
C10BX12 Atorvastatin, acetylsalicylic acid and perindopril
C10BX13 Rosuvastatin, perindopril and
indapamide
C10BX14 Rosuvastatin, amlodipine and perindopril
C10BX15 Atorvastatin and perindopril
C10BX16 Rosuvastatin and
fimasartan
C10BX17 Rosuvastatin and ramipril
C10BX18 Atorvastatin, amlodipine and ramipril
C10BX19 Atorvastatin, amlodipine and
candesartan
C10BX20 Rosuvastatin and
telmisartan
C10BX21 Rosuvastatin and
perindopril
References